Gecko Biomedical (“Gecko”), a French medical device company developing innovative polymers to support tissue healing, announces today that it has received an interest-free loan of 1.4 million euros from Bpifrance to advance its bio-inspired surgical adhesive solutions.
These funds will be dedicated to supporting Gecko Biomedical clinical trials in Europe in order to obtain CE Mark in the first half of 2017.
The funds are part of Bpifrance’s support of innovation through its interest-free loan program (Prêt à Taux Zéro pour l’Innovation -PTZI), providing repayable advances to encourage the development of innovative products.
Christophe Bancel, Gecko Biomedical’s Chief Executive Officer, said “Bpifrance’s continuous support not only provides us with financial stability towards our future, but also is a testimony of the value of our biopolymers platform. As such, Bpifrance is a central stakeholder to our short, medium and long-term development.”
